Healthcare
Priveq and Investor divest Vårdapoteket
Priveq Investment and Investor Growth Capital have agreed to sell their holdings in pharmacies operator Vårdapoteket to Apotek Hjärtat.
Novaliq raises €13.9m from Dievini Hopp
German drug delivery firm Novaliq GmbH has completed a fifth round of funding, raising €13.9m from existing backer Dievini Hopp.
Boehringer Ingelheim invests in Eyevensys
Boehringer Ingelheim Venture Fund (BIVF) has invested in French biotech company Eyevensys, marking the start of a new funding round for the business.
Sofinnova’s Omthera raises €48.8m in IPO
French investor Sofinnova Partners has completed the IPO of US-based portfolio company Omthera Pharmaceuticals on the Nasdaq Global Market in New York, raising €48.8m.
Graphite sells Optimum Care to Terra Firma's Four Seasons
Graphite Capital has sold elderly care provider Optimum Care to Four Seasons Health Care, backed by Terra Firma.
VC-backed SpineGuard to list on Alternext
SpineGuard, a French medical equipment producer backed by several venture capital firms including Omnes Capital, is set to list on NYSE Alternext by the end of April.
Water Street backs CCBR-SYNARC
Water Street Healthcare Partners has invested in Danish clinical services company CCBR-SYNARC.
KKR’s Pets at Home buys Vets4Pets
Pets at Home, a UK-based pet supplies retailer owned by KKR, has acquired Vets4Pets.
Eurazeo PME buys Idéal Résidences from LBO France
Eurazeo PME has acquired French medical and social healthcare provider Idéal Résidences from LBO France.
CDC Entreprises and Sofinnova invest €8m in MedDay
CDC Entreprises and Sofinnova Partners have made an €8m equity investment in French biotech firm MedDay.
Labco: formal bids expected next month
3i-backed medical diagnostics company Labco formally launched its sale process at the end of January and first bids are expected in May.
Segulah sells Medstop to Oriola-KD
Segulah has agreed to sell Medstop Group Holding AB to Oriola-KD Holding Sverige AB for SEK 1.46bn.
Isis commits £5m to Create Health
Isis Equity Partners has invested £5m in London-based fertility clinic Create Health.
Novartis, Index et al. lead €32m series-A for GenSight Biologics
Novartis Venture Fund, Abingworth, Versant Ventures and Index Ventures have co-led a €32m series-A funding round for French biotech business GenSight Biologics.
FSI et al. in €28m round for SuperSonic Imagine
A consortium of investors, led by the Fonds Stratégique d'Investissement (FSI) and comprising several European venture players, has provided ultrasound systems developer SuperSonic Imagine with a €28m round of funding.
Caixa and Inveready back Minoryx
Caixa Capital Risc and Inveready have taken part in a first round of funding for Minoryx, a therapeutic agents firm.
Permira acquires PharmaQ
Permira has agreed to acquire Norwegian health group PharmaQ Holding AS for €250m.
Bridgepoint acquires Oasis Healthcare from Duke Street
Bridgepoint Capital has acquired UK-based private dental healthcare provider Oasis Healthcare in a £185m secondary buyout from Duke Street.
Nordic Capital makes 5x on Permobil exit to Investor AB
Nordic Capital Fund V has agreed to sell Permobil,a Swedish rehabilitation power wheelchairs company to Investor AB for €655m.
HTGF et al. in €2.6m Transcatheter Tech series-B round
High-Tech Gründerfonds (HTGF), Tubaflex Beteiligungs GmbH and others have backed a €2.6m series-B round for German biotech business Transcatheter Technologies, a developer of transcatheter heart valve technology.
Invesco backs infirst with £25m
Invesco Asset Management has invested £25m in infirst Healthcare, a British healthcare company providing consumer medicines.
PVP closes €3m series-A for CryoTherapeutics
Peppermint Venture Partners (PVP) has joined an investor consortium including High-Tech Gründerfonds (HTGF) in a €3m series-A round for German biotech company CryoTherapeutics.
Enterprise takes stake in Nu-Med
Enterprise Investors has backed Polish radiotherapy centre operator Nu-Med, taking a minority stake.
LDC backs NRS Healthcare MBO
LDC has taken a stake in the £24m management buyout of NRS Healthcare, the healthcare division of listed multi-channel retailer Findel plc.